Keith Brunt was appointed Director of ProtoKinetix, Inc. As of November 6, 2026, ProtoKinetix, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on June 17, 2026, naming 1 appointment (Form 8-K, June 17, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like ProtoKinetix, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
ProtoKinetix, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-06-17. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as ProtoKinetix, Inc. files it.
Also on the record for ProtoKinetix, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 4, 2026 | Form D amendment, private offering | $206K sold | Form D page | Source |
Selling to them or working with them? See who runs ProtoKinetix, Inc. now and the warning signs.
Free to see. No signup.
Watch ProtoKinetix, Inc.
Get an email when ProtoKinetix, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on ProtoKinetix, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on ProtoKinetix, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on ProtoKinetix, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
2 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-06-17 | In | Director | 8-K, 2026-06-17 |
Who leads ProtoKinetix, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Keith Brunt, appointed (filed 2026-06-17).
New leaders reset buying decisions — get the Full Report on ProtoKinetix, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at ProtoKinetix, Inc., with the record behind each one.
Find candidates like Director at ProtoKinetix, Inc.Every change, in the filing's words
Appointed: Keith Brunt, Director
On June 17, 2026, Keith Brunt, a Translational Scientist and Associate Professor of Pharmacology, in the Faculty of Medicine at Dalhousie Medicine in New Brunswick, was appointed as a director and as the president of the Company, to hold such office until his successors are duly elected and qualified.
- On March 31, 2026, Mr. Edward McDonough, after serving many years as a trusted advisor to ProtoKinetix, Incorporated (the "Company") under the leadership of Clarence E. Smith, notified the Board of Directors of the Company (the "Board") of his resignation from the Board effective immediately.
- His decision to resign from the Board was not related to any disagreement with the Company on any matter relating to its operations, policies or practices.
- On June 17, 2026, Michael Jones, of Corbin, Kentucky, and Jason Lamp, of Roswell, Georgia were appointed as directors of the Company to serve as members of the Board, and to hold such office until their successors are duly elected and qualified.
- Mr. Lamp and Mr. Jones are both seasoned entrepreneurs and longtime stockholders of the Company.
- Dr. Keith R. Brunt, age 47, is an Associate Professor of the Department of Pharmacology in the Faculty of Medicine at Dalhousie University; Adjunct Professor in the Faculty of Business at the University of New Brunswick; and a Translational Scientist at the New Brunswick Heart Centre.
- Dr. Brunt has served as a director and executive on several boards in both non-profit research organizations and for-profit companies, including as a director of Routinify Inc. from 2019-2024, and as the Chair of the Board of Directors of Heart & Stroke Foundation New Brunswick from 2021-2024.
Tools for this story
Each opens in a new tab, filled in for ProtoKinetix, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.